48 related articles for article (PubMed ID: 12229940)
1. Serous borderline tumor of the ovary with isolated cardiophrenic lymph node spread at diagnosis.
St Laurent JD; Gockley AA; Cathcart AM; Baranov E; Kolin DL; Worley MJ
Gynecol Oncol Rep; 2020 Aug; 33():100586. PubMed ID: 32529019
[TBL] [Abstract][Full Text] [Related]
2. Lymph node involvement in an ovarian borderline serous tumor: a rare clinicopathologic presentation with management dilemma.
Aggarwal D; Gupta P; Bagga R; Srinivasan R; Das CK
Am J Transl Res; 2023; 15(11):6667-6672. PubMed ID: 38074826
[TBL] [Abstract][Full Text] [Related]
3. Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature.
Wetterwald L; Sarivalasis A; Liapi A; Mathevet P; Achtari C
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765848
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative Appearance of Endosalpingiosis: A Single-Center Experience of Laparoscopic Findings and Systematic Review of Literature.
Burla L; Kalaitzopoulos DR; Mrozek A; Eberhard M; Samartzis N
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498581
[TBL] [Abstract][Full Text] [Related]
5. A retrospective analysis of relapse-related factors for ovarian borderline tumors.
Ye D; Shen H; Huang W; Yao L
Am J Transl Res; 2022; 14(8):5712-5718. PubMed ID: 36105008
[TBL] [Abstract][Full Text] [Related]
6. Predicting Lymph Node Involvement in Borderline Ovarian Tumors with a Quantitative Model and Nomogram: A Retrospective Cohort Study.
Zhang M; Zhou F; He Y; Tao X; Hua K; Ding J
Cancer Manag Res; 2021; 13():1529-1539. PubMed ID: 33623432
[TBL] [Abstract][Full Text] [Related]
7. Significance of lymph node ratio on survival of women with borderline ovarian tumors.
Nusbaum DJ; Mandelbaum RS; Machida H; Matsuzaki S; Roman LD; Sood AK; Gershenson DM; Matsuo K
Arch Gynecol Obstet; 2020 May; 301(5):1289-1298. PubMed ID: 32303888
[TBL] [Abstract][Full Text] [Related]
8. Tumors of low malignant potential a single institution experience.
Jbir I; Ghalleb M; Triki A; Zemni I; Hechiche M; Ben Hassouna J; Rahal K
Int J Surg Case Rep; 2019; 55():41-46. PubMed ID: 30684818
[TBL] [Abstract][Full Text] [Related]
9. The safety of fertility and ipsilateral ovary procedures for borderline ovarian tumors.
Lou T; Yuan F; Feng Y; Wang S; Bai H; Zhang Z
Oncotarget; 2017 Dec; 8(70):115718-115729. PubMed ID: 29383195
[TBL] [Abstract][Full Text] [Related]
10. Fine needle aspiration cytology of cervical lymph node involvement by ovarian serous borderline tumor.
Chen L; Butler KA; Bell DA
Cytojournal; 2016; 13():16. PubMed ID: 27563339
[TBL] [Abstract][Full Text] [Related]
11. Borderline ovarian tumors: a study of 100 cases from a Tertiary Care Hospital.
Uysal A; Mun S; Uysal F; Oztekin M; Büyüktosun C; Sehirali S; Başoğul O; Taner CE
Contemp Oncol (Pozn); 2013; 17(3):307-10. PubMed ID: 24596520
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases.
Maniar KP; Wang Y; Visvanathan K; Shih IeM; Kurman RJ
Am J Surg Pathol; 2014 Jun; 38(6):743-55. PubMed ID: 24441661
[TBL] [Abstract][Full Text] [Related]
13. Incomplete staging surgery as a major predictor of relapse of borderline ovarian tumor.
Romeo M; Pons F; Barretina P; Radua J
World J Surg Oncol; 2013 Jan; 11():13. PubMed ID: 23343188
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube.
Carlson J; Roh MH; Chang MC; Crum CP
Diagn Histopathol (Oxf); 2008 Aug; 14(8):352-365. PubMed ID: 20953242
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome and risk factors for recurrence in borderline ovarian tumours.
Yokoyama Y; Moriya T; Takano T; Shoji T; Takahashi O; Nakahara K; Yamada H; Yaegashi N; Okamura K; Izutsu T; Sugiyama T; Tanaka T; Kurachi H; Sato A; Tase T; Mizunuma H
Br J Cancer; 2006 Jun; 94(11):1586-91. PubMed ID: 16685277
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
Casey MJ; Bewtra C
Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
[TBL] [Abstract][Full Text] [Related]
17. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor: an analysis of a series of 42 lymphadenectomies.
Camatte S; Morice P; Atallah D; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
J Am Coll Surg; 2002 Sep; 195(3):332-8. PubMed ID: 12229940
[TBL] [Abstract][Full Text] [Related]
18. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
